Skip to main content

. 1991 Dec;54(12):1121–1122. doi: 10.1136/jnnp.54.12.1121-a

Progressive supranuclear palsy as the sole manifestation of systemic Whipple's disease treated with pefloxacine.

P Amarenco, E Roullet, L Hannoun, R Marteau

PMCID: PMC1014700 PMID: 1723749

1121

Images in this article

Image
on p.1121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Adams M., Rhyner P. A., Day J., DeArmond S., Smuckler E. A. Whipple's disease confined to the central nervous system. Ann Neurol. 1987 Jan;21(1):104–108. doi: 10.1002/ana.410210121. [DOI] [PubMed] [Google Scholar]
Adler C. H., Galetta S. L. Oculo-facial-skeletal myorhythmia in Whipple disease: treatment with ceftriaxone. Ann Intern Med. 1990 Mar 15;112(6):467–469. doi: 10.7326/0003-4819-76-3-112-6-467. [DOI] [PubMed] [Google Scholar]
Hausser-Hauw C., Roullet E., Robert R., Marteau R. Oculo-facio-skeletal myorhythmia as a cerebral complication of systemic Whipple's disease. Mov Disord. 1988;3(2):179–184. doi: 10.1002/mds.870030211. [DOI] [PubMed] [Google Scholar]
Keinath R. D., Merrell D. E., Vlietstra R., Dobbins W. O., 3rd Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients. Gastroenterology. 1985 Jun;88(6):1867–1873. doi: 10.1016/0016-5085(85)90012-5. [DOI] [PubMed] [Google Scholar]
Riggs J. E. The evolving natural history of neurologic involvement in Whipple disease: a hypothesis. Arch Neurol. 1988 Aug;45(8):830–830. doi: 10.1001/archneur.1988.00520320016003. [DOI] [PubMed] [Google Scholar]
Ryser R. J., Locksley R. M., Eng S. C., Dobbins W. O., 3rd, Schoenknecht F. D., Rubin C. E. Reversal of dementia associated with Whipple's disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier. Gastroenterology. 1984 Apr;86(4):745–752. [PubMed] [Google Scholar]

ACTIONS

RESOURCES